Metabolic and cytokinic factors determine alternative splicing, and we and others have shown that, in patients with MS, Treg cells express reduced levels of FoxP3-E2 and are thus deprived of an auxiliary level of regulation (27, 28). The gene discussed is FOXP3; the disease is myeloid sarcoma.